Hans Hull, Chief Business Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 17,496 shares at $19.10 ($334K) on 2022-12-20, disclosed to the SEC on 2022-12-21.
Open-market sale of $334k PLRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.10 | 8,748 | $167K | 50.0% |
| 2 | $19.10 | 8,748 | $167K | 50.0% |
| Total | $19.10 avg | 17,496 | $334K | 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-08-07 | $1.1M | — | Filing → |
| PLRX | SELL | 2023-07-19 | $646K | — | Filing → |